Oruka Therapeutics (ORKA) Interest Coverage Ratio Growth (1y) (2011 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 20.21% |
| Jun 30, 2020 | 13.13% |
| Mar 31, 2020 | 43.57% |
| Sep 30, 2019 | -50.06% |
| Jun 30, 2019 | 30.06% |
| Mar 31, 2019 | 35.77% |
| Sep 30, 2018 | 62.86% |
| Jun 30, 2018 | 74.14% |
| Mar 31, 2018 | 57.80% |
| Sep 30, 2015 | -23.28% |
| Jun 30, 2015 | 43.50% |
| Mar 31, 2015 | -14.81% |
| Jun 30, 2014 | -301.67% |
| Mar 31, 2014 | -123.36% |
| Jun 30, 2013 | -4.63% |
| Mar 31, 2013 | 23.90% |
| Sep 30, 2012 | -1.92% |
| Jun 30, 2012 | 32.81% |
| Mar 31, 2012 | -219.26% |
| Dec 31, 2011 | 117.37% |
| Sep 30, 2011 | -29.70% |
| Jun 30, 2011 | 24.90% |